The Laminin Receptors in Kidney Fibrosis
The Laminin Receptors in Kidney Fibrosis
批准号:
10368972
负责人:
ROY ZENT
金额:
$50.78万
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
已结题
起止时间:
2020-06-08 至 2023-07-31
关键词:
AdhesionsAgeAgingAnimalsApoptosisApoptoticBiochemicalBiologicalBiological AssayCell physiologyCellsChronicChronic Kidney FailureCollagenCytoplasmic TailDataDefectDevelopmentDilatation - actionDiseaseDuctal Epithelial CellEpithelial CellsExtracellular DomainExtracellular MatrixFibrosisGoalsGrantHealthHomeostasisHumanInflammationInflammatoryInflammatory ResponseInjuryInjury to KidneyIntegrin BindingIntegrin alpha3Integrin alpha3beta1Integrin alpha6IntegrinsKidneyKnockout MiceKnowledgeLamininLaminin ReceptorLigand BindingLigandsMediatingMetanephric DiverticulumMinorMorphologyMusMutationNephrotic SyndromeNull LymphocytesObstructionPhenotypeProcessProductionPropertyRenal tubule structureSignal PathwaySignal TransductionSpecificitySystemTestingTransgenic MiceTransmembrane DomainTubular formationagedcell injurycytokinedefined contributiondimerepithelial injuryinjuredinsightkidney epithelial cellkidney fibrosismouse modelnovelreceptorreceptor bindingresponse
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Our overall goal is to define how cell-extracellular matrix interactions regulate kidney homeostasis in health and
disease. These interactions are studied from animals to molecules using transgenic mouse models, cell
biological and biochemical assays. We previously defined the contribution of laminin (LM) receptor integrins,
integrin α3β1 and α6 containing integrins, to ureteric bud (UB) development. Recently, we made an unexpected
novel observation that LM receptors regulate tubular epithelial cell inflammation and kidney tubulointerstitial
fibrosis in aged and injured mice. These new findings form the basis of this renewal.
Integrins are transmembrane receptors composed of α and β subunits that mediate interactions between cells
and ECM. There are 18 α and 8 β subunits, which form dimers with different ligand binding properties. Integrins
are classified into collagen, LM and RGD binding receptors and the principal LM binding integrins are α3β1,
α6β1 and α6β4. Ligand specificity is defined by the extracellular domain while the transmembrane domain (TM)
and the cytoplasmic tail mediate specialized functional intracellular signaling. In the last grant cycle, we showed
that deleting the integrin (Itg) α3 subunit in the UB causes minor morphological developmental abnormalities,
while deleting the Itgα6 subunit did not alter development. Mice lacking Itgα3 in the UB are highly susceptible to
kidney fibrosis after unilateral ureteric obstruction (UUO), while the integrin Itgα6-null mice develop severe
tubular dilatation and cellular apoptosis, but no fibrosis. Mice lacking all LM binding integrins in the UB (Itgα3/α6-
null) have the same developmental phenotype as the Itgα3-null mice, but with age they develop severe
tubulointerstitial fibrosis and inflammation. These mice are also susceptible to severe inflammation, fibrosis and
tubular apoptosis after UUO and chronic proximal tubule injury. Utilizing collecting duct cells from these mice,
we show that in addition to their classical adhesion functions, the LM binding integrins regulate epithelial cell
apoptosis, inflammation and collagen production. Excess collagen synthesis occurs when Itgα3 is deleted,
apoptosis when α6 is deleted and, in addition to these processes, inflammation occurs in Itgα3/α6-null mice. In
this proposal, we will investigate the mechanisms whereby the LM-binding receptors regulate renal tubular
epithelial cell responses to aging and injury. We will test the hypothesis that loss of kidney tubule epithelial
cell signaling from LMs, via α3β1 an α6-containing integrins, causes accelerated inflammation and
excessive fibrosis and apoptosis resulting in chronic kidney disease in the following aims: 1) Define the
mechanisms whereby loss of LM binding integrin signaling predisposes kidney tubules to chronic
kidney injury. 2) Determine the mechanisms whereby the loss of LM binding integrin signaling promotes
renal tubular epithelial cell apoptosis, inflammation and collagen production.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The Laminin Receptors in Kidney Fibrosis
-
批准号:9914510
-
项目类别:
-
资助金额:$50.78万
-
财政年份:2020
-
负责人:ROY ZENT
-
依托单位:
The Laminin Receptors in Kidney Fibrosis
-
批准号:10186731
-
项目类别:
-
资助金额:$50.78万
-
财政年份:2020
-
负责人:ROY ZENT
-
依托单位:
ORD Shared Equipment Evaluation Program (ShEEP) (IS1) - Zeiss LSM980 Airyscan Confocal Microscope
-
批准号:10180502
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2020
-
负责人:ROY ZENT
-
依托单位:
2019 Fibronectin, Integrins and Related Molecules GRC/GRS
-
批准号:9751563
-
项目类别:
-
资助金额:$1.5万
-
财政年份:2019
-
负责人:ROY ZENT
-
依托单位:
Vanderbilt O'Brien Kidney Center - Core C Cell and Genome Engineering
-
批准号:10163168
-
项目类别:
-
资助金额:$14.22万
-
财政年份:2017
-
负责人:ROY ZENT
-
依托单位:
The ILK/PINCH/Parvin complex in renal tubulogenesis
-
批准号:8543139
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2013
-
负责人:ROY ZENT
-
依托单位:
The ILK/PINCH/Parvin complex in renal tubulogenesis
-
批准号:8687966
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2013
-
负责人:ROY ZENT
-
依托单位:
lntegrin binding proteins and the kidney
-
批准号:10587019
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2013
-
负责人:ROY ZENT
-
依托单位:
The ILK/PINCH/Parvin complex in renal tubulogenesis
-
批准号:8803371
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2013
-
负责人:ROY ZENT
-
依托单位:
Betal Integrin and Renal Tubulogenesis
-
批准号:8668041
-
项目类别:
-
资助金额:$33.93万
-
财政年份:2008
-
负责人:ROY ZENT
-
依托单位:
Betal Integrin and Renal Tubulogenesis
-
批准号:8856546
-
项目类别:
-
资助金额:$33.93万
-
财政年份:2008
-
负责人:ROY ZENT
-
依托单位:
Betal Integrin and Renal Tubulogenesis
-
批准号:8514584
-
项目类别:
-
资助金额:$32.74万
-
财政年份:2008
-
负责人:ROY ZENT
-
依托单位:
Betal Integrin and Renal Tubulogenesis
-
批准号:8320492
-
项目类别:
-
资助金额:$33.93万
-
财政年份:2008
-
负责人:ROY ZENT
-
依托单位:
THE MATRIX BIOLOGY CORE
-
批准号:7568459
-
项目类别:
-
资助金额:$17.05万
-
财政年份:2008
-
负责人:ROY ZENT
-
依托单位:
Beta1 integrin and renal tubulogenesis
-
批准号:7579133
-
项目类别:
-
资助金额:$32.62万
-
财政年份:2008
-
负责人:ROY ZENT
-
依托单位:
Beta1 integrin and renal tubulogenesis
-
批准号:7373244
-
项目类别:
-
资助金额:$32.62万
-
财政年份:2008
-
负责人:ROY ZENT
-
依托单位:
Beta1 integrin and renal tubulogenesis
-
批准号:8038461
-
项目类别:
-
资助金额:$31.97万
-
财政年份:2008
-
负责人:ROY ZENT
-
依托单位:
Role of MT-Matrix Metalloproteins (MMPs) in Renal Development
-
批准号:7348411
-
项目类别:
-
资助金额:$36.26万
-
财政年份:2005
-
负责人:ROY ZENT
-
依托单位:
Role of MT-MMPs in Renal Development
-
批准号:7489677
-
项目类别:
-
资助金额:$2.63万
-
财政年份:2005
-
负责人:ROY ZENT
-
依托单位:
The Laminin Receptors in Kidney Development
-
批准号:9322121
-
项目类别:
-
资助金额:$49.38万
-
财政年份:2005
-
负责人:ROY ZENT
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: